CORCEPT THERAPEUTICS INC Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Corcept Therapeutics Inc quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Corcept Therapeutics Inc Return On Assets for the quarter ending September 30, 2024 was 20.4 %, a 29.7% increase year-over-year.
  • Corcept Therapeutics Inc annual Return On Assets for 2023 was 18 %, a 7.64% decline from 2022.
  • Corcept Therapeutics Inc annual Return On Assets for 2022 was 19.5 %, a 7.76% decline from 2021.
  • Corcept Therapeutics Inc annual Return On Assets for 2021 was 21.1 %, a 2.13% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 20.4 +4.68 +29.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 19.5 +2.73 +16.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 19.7 +2.76 +16.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 18 -1.49 -7.64% Oct 1, 2023 Dec 31, 2023
Q3 2023 15.8 -8.57 -35.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 16.8 -6.1 -26.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 16.9 -4.92 -22.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 19.5 -1.64 -7.76% Oct 1, 2022 Dec 31, 2022
Q3 2022 24.3 +5.64 +30.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 22.9 +5.31 +30.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 21.9 +3.43 +18.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 21.1 +0.44 +2.13% Oct 1, 2021 Dec 31, 2021
Q3 2021 18.7 -4.46 -19.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 17.5 -8.96 -33.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 18.4 -8.84 -32.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 20.7 -5.68 -21.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 23.2 -3 -11.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 26.5 +1.67 +6.73% Apr 1, 2020 Jun 30, 2020
Q1 2020 27.3 +2 +7.91% Jan 1, 2020 Mar 31, 2020
Q4 2019 26.4 -0.35 -1.31% Oct 1, 2019 Dec 31, 2019
Q3 2019 26.2 -32.3 -55.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 24.8 -44.8 -64.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 25.3 -60.8 -70.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 26.7 -78 -74.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 58.5 +17 +41% Jul 1, 2018 Sep 30, 2018
Q2 2018 69.6 +36.7 +111% Apr 1, 2018 Jun 30, 2018
Q1 2018 86.1 +67.1 +353% Jan 1, 2018 Mar 31, 2018
Q4 2017 105 +123 Oct 1, 2017 Dec 31, 2017
Q3 2017 41.5 +67.3 Jul 1, 2017 Sep 30, 2017
Q2 2017 33 +66.6 Apr 1, 2017 Jun 30, 2017
Q1 2017 19 +59.9 Jan 1, 2017 Mar 31, 2017
Q4 2016 -18 -4.94 -37.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -25.8 -0.7 -2.79% Jul 1, 2016 Sep 30, 2016
Q2 2016 -33.6 +5.95 +15% Apr 1, 2016 Jun 30, 2016
Q1 2016 -40.8 +13.4 +24.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -13 +61.3 +82.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -25.1 +53.1 +67.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 -39.6 +35.6 +47.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 -54.2 +17.6 +24.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -74.3 -13.3 -21.9% Oct 1, 2014 Dec 31, 2014
Q3 2014 -78.2 -23.8 -43.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -75.2 -28.6 -61.4% Apr 1, 2014 Jun 30, 2014
Q1 2014 -71.8 -24.6 -52.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -61 -7.77 -14.6% Oct 1, 2013 Dec 31, 2013
Q3 2013 -54.4 +10.6 +16.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 -46.6 +36.9 +44.2% Apr 1, 2013 Jun 30, 2013
Q1 2013 -47.2 +32.7 +40.9% Jan 1, 2013 Mar 31, 2013
Q4 2012 -53.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 -65 Jul 1, 2012 Sep 30, 2012
Q2 2012 -83.5 Apr 1, 2012 Jun 30, 2012
Q1 2012 -79.8 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.